Market Overview:
The global adrenocortical carcinoma treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of adrenocortical carcinoma, rising awareness about the disease, and technological advancements in the field of cancer treatment. However, high cost of treatment and lack of reimbursement are some factors that are restraining the growth of this market. The global adrenocortical carcinoma treatment market is segmented on the basis of type, application, and region. On the basis of type, it is divided into localized adrenocortical carcinoma and metastatic adrenocortical carcinoma. On the basis on application, it is segmented into hospitals, ambulatory surgical centers (ASCs), clinics, and cancer research institutes (CRIs).
Product Definition:
Adrenocortical carcinoma is a rare cancer that starts in the cells of the adrenal gland. The adrenal gland is located just above the kidney. It makes hormones that help control heart rate, blood pressure, and other important body functions.
Localized Adrenocortical Carcinoma:
Adrenocortical carcinoma is a type of cancer that begins in the adrenal glands. The most common symptoms include weakness, fatigue, nausea, vomiting, and weight loss. As the disease advances it can lead to high blood pressure (hypertension), heart problems and diabetes mellitus.
Metastatic Adrenocortical Carcinoma:
Metastatic adrenocortical carcinoma is a type of cancer that starts in the adrenal glands and then spreads to other parts of the body. The most common symptom associated with this form of cancer is excessive sweating, especially under the arms or between the legs. Other symptoms include fatigue, weakness, nausea or vomiting, low blood pressure (hypotension), diarrhea or stomach pain along with weight loss.
Application Insights:
The clinics segment dominated the global application market in 2017. This is owing to a large patient base and increasing awareness about the disease. In addition, an increase in the adoption of minimally invasive treatments such as laparoscopic adrenocortical carcinoma surgeries by clinics has led to higher penetration rates. The hospitals segment is expected to witness lucrative growth over the forecast period due to a rise in demand for highly skilled surgeons and oncologists, availability of advanced healthcare facilities along with ongoing research for new treatment modalities at major cancer research institutes across the globe.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, availability of advanced treatment options, high awareness levels coupled with a supportive reimbursement framework in this region. In addition, increasing government initiatives and rising healthcare expenditure are also expected to drive growth during the forecast period.
Growth Factors:
- Increasing incidence of adrenocortical carcinoma
- Growing awareness about the disease among people
- Rising demand for better and advanced treatment options for adrenocortical carcinoma patients
- Availability of government funding for research on adrenocortical carcinoma treatment
- Technological advancements in the field of cancer treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Adrenocortical Carcinoma Treatment Market Research Report
By Type
Localized Adrenocortical Carcinoma, Metastatic Adrenocortical Carcinoma
By Application
Hospitals, Ambulatory Surgical Centers, Clinics, Cancer Research Institutes
By Companies
ArQule, EnGeneIC, Exelixis, Merck, Millendo Therapeutics, Orphagen Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Adrenocortical Carcinoma Treatment Market Report Segments:
The global Adrenocortical Carcinoma Treatment market is segmented on the basis of:
Types
Localized Adrenocortical Carcinoma, Metastatic Adrenocortical Carcinoma
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Clinics, Cancer Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ArQule
- EnGeneIC
- Exelixis
- Merck
- Millendo Therapeutics
- Orphagen Pharmaceuticals
Highlights of The Adrenocortical Carcinoma Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Localized Adrenocortical Carcinoma
- Metastatic Adrenocortical Carcinoma
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Cancer Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Adrenocortical Carcinoma Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Adrenocortical carcinoma is a type of cancer that arises from the adrenal gland. Treatment typically includes surgery, radiation therapy, and chemotherapy.
Some of the major players in the adrenocortical carcinoma treatment market are ArQule, EnGeneIC, Exelixis, Merck, Millendo Therapeutics, Orphagen Pharmaceuticals.
The adrenocortical carcinoma treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Adrenocortical Carcinoma Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Adrenocortical Carcinoma Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Adrenocortical Carcinoma Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Adrenocortical Carcinoma Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Adrenocortical Carcinoma Treatment Market Size & Forecast, 2018-2028
4.5.1 Adrenocortical Carcinoma Treatment Market Size and Y-o-Y Growth
4.5.2 Adrenocortical Carcinoma Treatment Market Absolute $ Opportunity
Chapter 5 Global Adrenocortical Carcinoma Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Adrenocortical Carcinoma Treatment Market Size Forecast by Type
5.2.1 Localized Adrenocortical Carcinoma
5.2.2 Metastatic Adrenocortical Carcinoma
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Adrenocortical Carcinoma Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Adrenocortical Carcinoma Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Clinics
6.2.4 Cancer Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Adrenocortical Carcinoma Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Adrenocortical Carcinoma Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Adrenocortical Carcinoma Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Adrenocortical Carcinoma Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Adrenocortical Carcinoma Treatment Market Size Forecast by Type
9.6.1 Localized Adrenocortical Carcinoma
9.6.2 Metastatic Adrenocortical Carcinoma
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Adrenocortical Carcinoma Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Clinics
9.10.4 Cancer Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Adrenocortical Carcinoma Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Adrenocortical Carcinoma Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Adrenocortical Carcinoma Treatment Market Size Forecast by Type
10.6.1 Localized Adrenocortical Carcinoma
10.6.2 Metastatic Adrenocortical Carcinoma
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Adrenocortical Carcinoma Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Clinics
10.10.4 Cancer Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Adrenocortical Carcinoma Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Adrenocortical Carcinoma Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Adrenocortical Carcinoma Treatment Market Size Forecast by Type
11.6.1 Localized Adrenocortical Carcinoma
11.6.2 Metastatic Adrenocortical Carcinoma
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Adrenocortical Carcinoma Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Clinics
11.10.4 Cancer Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Adrenocortical Carcinoma Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Adrenocortical Carcinoma Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Adrenocortical Carcinoma Treatment Market Size Forecast by Type
12.6.1 Localized Adrenocortical Carcinoma
12.6.2 Metastatic Adrenocortical Carcinoma
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Adrenocortical Carcinoma Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Clinics
12.10.4 Cancer Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Adrenocortical Carcinoma Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Adrenocortical Carcinoma Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Adrenocortical Carcinoma Treatment Market Size Forecast by Type
13.6.1 Localized Adrenocortical Carcinoma
13.6.2 Metastatic Adrenocortical Carcinoma
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Adrenocortical Carcinoma Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Clinics
13.10.4 Cancer Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Adrenocortical Carcinoma Treatment Market: Competitive Dashboard
14.2 Global Adrenocortical Carcinoma Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ArQule
14.3.2 EnGeneIC
14.3.3 Exelixis
14.3.4 Merck
14.3.5 Millendo Therapeutics
14.3.6 Orphagen Pharmaceuticals
